Bank Julius Baer & Co. Ltd, Zurich Biomarin Pharmaceutical Inc Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $595,051 - $702,900	-7,100 Reduced 55.51%	5,690 $496,000
Q4 2023 May 16, 2024	BUY	$76.22 - $98.51 $541,162 - $699,421	7,100 Added 124.78%	12,790 $1.23 Million
Q4 2023 Feb 02, 2024	SELL	$76.22 - $98.51 $105,564 - $136,436	-1,385 Reduced 9.77%	12,790 $1.23 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $780,602 - $866,948	9,176 Added 183.56%	14,175 $1.25 Million
Q2 2023 Jul 24, 2023	BUY	$86.68 - $100.3 $433,313 - $501,399	4,999 New	4,999 $433,000
Q1 2023 May 11, 2023	SELL	$87.74 - $117.27 $211,892 - $283,207	-2,415 Reduced 25.06%	7,223 $702,000
Q4 2022 Jan 24, 2023	SELL	$80.93 - $108.63 $181,849 - $244,091	-2,247 Reduced 18.91%	9,638 $997,000
Q3 2022 Nov 04, 2022	BUY	$82.16 - $96.94 $394,943 - $465,990	4,807 Added 67.91%	11,885 $1.01 Million
Q2 2022 Jul 22, 2022	SELL	$71.48 - $86.85 $36,812 - $44,727	-515 Reduced 6.78%	7,078 $587,000
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $161,930 - $202,064	2,180 Added 40.27%	7,593 $585,000
Q4 2021 Feb 15, 2022	SELL	$71.72 - $91.47 $153,265 - $195,471	-2,137 Reduced 28.3%	5,413 $478,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $123,669 - $141,367	-1,654 Reduced 17.97%	7,550 $584,000
Q2 2021 Jul 23, 2021	BUY	$75.51 - $84.79 $146,942 - $165,001	1,946 Added 26.81%	9,204 $768,000
Q1 2021 May 10, 2021	SELL	$74.73 - $90.69 $507,491 - $615,875	-6,791 Reduced 48.34%	7,258 $548,000
Q4 2020 Feb 24, 2021	SELL	$72.61 - $90.2 $950,900 - $1.18 Million	-13,096 Reduced 48.24%	14,049 $1.23 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $1.44 Million - $1.79 Million	19,844 Added 271.8%	27,145 $1.23 Million
Q3 2020 Nov 10, 2020	BUY	$71.87 - $131.03 $42,475 - $77,438	591 Added 8.81%	7,301 $55,000
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $176,521 - $275,644	2,219 Added 49.41%	6,710 $828,000
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $320,522 - $434,953	4,491 New	4,491 $379,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account